Loading...
Sabra Health Care REIT reported a net loss for Q3 2022, but also reported positive normalized FFO and AFFO. The company is transitioning the North American portfolio to Ensign and Avamere, and is making progress on additional dispositions.
Net Loss: $(0.22) per share
FFO: $0.28 per share
Normalized FFO: $0.36 per share
AFFO: $0.34 per share
Sabra expects to reduce leverage closer to its 5.0x long-term leverage target by the end of the year with proceeds from disposition activity. The transition of facilities to Ensign and Avamere is expected to be completed by February 1, 2023.
Visualization of income flow from segment revenue to net income